Liposarcoma News and Research

RSS
FDA grants accelerated approval for first engineered T cell therapy to treat adults with synovial sarcoma

FDA grants accelerated approval for first engineered T cell therapy to treat adults with synovial sarcoma

SU2C-SARC032 trial: Immunotherapy reduces relapse risk in soft tissue sarcoma by 43%

SU2C-SARC032 trial: Immunotherapy reduces relapse risk in soft tissue sarcoma by 43%

New platform technology bridges the gap between microscopic analysis and multiplex imaging

New platform technology bridges the gap between microscopic analysis and multiplex imaging

Phase I clinical study of TCR NK cell therapy for sarcoma expected to commence later this year

Phase I clinical study of TCR NK cell therapy for sarcoma expected to commence later this year

Pathologic complete response can be used as a prognostic factor for clinical outcomes in soft tissue sarcoma patients

Pathologic complete response can be used as a prognostic factor for clinical outcomes in soft tissue sarcoma patients

Using a long-read approach to gain better understanding of DNA mutations in cancer genomes

Using a long-read approach to gain better understanding of DNA mutations in cancer genomes

Study generates a comprehensive genetic map to identify important genes that cause sarcoma

Study generates a comprehensive genetic map to identify important genes that cause sarcoma

Researchers create large-scale 2D and 3D spatial maps of colorectal cancer

Researchers create large-scale 2D and 3D spatial maps of colorectal cancer

Novel T cell receptor therapy shows early promise for treating solid tumors

Novel T cell receptor therapy shows early promise for treating solid tumors

Five-day course of preoperative radiation therapy for sarcoma provides excellent local control rates

Five-day course of preoperative radiation therapy for sarcoma provides excellent local control rates

Adaptimmune to report Phase 2 trial data on synovial sarcoma at ASCO congress

Adaptimmune to report Phase 2 trial data on synovial sarcoma at ASCO congress

Gene panel test enables highly accurate diagnosis of liposarcomas

Gene panel test enables highly accurate diagnosis of liposarcomas

Improving cancer therapies by exploiting drug resistance in cancer

Improving cancer therapies by exploiting drug resistance in cancer

Adoptive T-cell therapy targeting MAGE-A4 achieves responses in patients with multiple solid tumors

Adoptive T-cell therapy targeting MAGE-A4 achieves responses in patients with multiple solid tumors

Targeting HDAC2 reduces MDM2 expression and has anti-tumor effects in dedifferentiated liposarcoma

Targeting HDAC2 reduces MDM2 expression and has anti-tumor effects in dedifferentiated liposarcoma

Harvard chemists achieve landmark in drug discovery with synthesis of potent anti-cancer agent

Harvard chemists achieve landmark in drug discovery with synthesis of potent anti-cancer agent

Study identifies promising cancer target for liposarcoma

Study identifies promising cancer target for liposarcoma

Different levels of two molecules from same family can influence prognosis of liposarcoma

Different levels of two molecules from same family can influence prognosis of liposarcoma

Scientists receive critical funding to study treatments for three deadly cancers

Scientists receive critical funding to study treatments for three deadly cancers

Early study of experimental vaccine shows escalating immune response in patients with sarcoma

Early study of experimental vaccine shows escalating immune response in patients with sarcoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.